Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 11:41 am Purchase | 2024-02-08 | 13G | Adverum Biotechnologies, Inc. ADVM | Frazier Life Sciences Public Fund, L.P. | 1,041,667 11.000% | 1,041,667 (New Position) | Filing History |
| 2024-01-25 1:24 pm Purchase | 2024-01-23 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Frazier Life Sciences Public Fund, L.P. | 4,142,855 6.200% | 4,142,855 (New Position) | Filing History |
| 2023-12-14 1:33 pm Purchase | 2023-12-12 | 13D | KalVista Pharmaceuticals, Inc. KALV | Frazier Life Sciences Public Fund, L.P. | 3,582,294 10.400% | 343,435 (+10.60%) | Filing History |
| 2023-10-05 12:23 pm Sale | 2023-10-03 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Frazier Life Sciences Public Fund, L.P. | 0 0.000% | -3,708,838 (Position Closed) | Filing History |
| 2023-09-27 10:26 am Purchase | 2023-09-25 | 13D | HilleVax, Inc. HLVX | Frazier Life Sciences Public Fund, L.P. | 9,806,472 20.200% | 25,000 (+0.26%) | Filing History |
| 2023-05-26 5:29 pm Purchase | 2023-05-24 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences Public Fund, L.P. | 10,125,788 18.500% | 1,697,683 (+20.14%) | Filing History |
| 2023-05-05 4:13 pm Purchase | 2023-04-13 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences Public Fund, L.P. | 8,428,105 19.300% | 8,428,105 (New Position) | Filing History |
| 2023-05-05 4:12 pm Purchase | 2023-04-28 | 13D | HilleVax, Inc. HLVX | Frazier Life Sciences Public Fund, L.P. | 9,781,472 25.000% | 144,240 (+1.50%) | Filing History |
| 2023-04-17 5:29 pm Sale | 2023-04-13 | 13G | Allakos Inc. ALLK | Frazier Life Sciences Public Fund, L.P. | 392,269 0.500% | -4,399,731 (-91.81%) | Filing History |
| 2023-02-14 12:19 pm Sale | 2022-12-31 | 13G | Cogent Biosciences, Inc. COGT | Frazier Life Sciences Public Fund, L.P. | 2,109,154 3.000% | -78,850 (-3.60%) | Filing History |
| 2023-02-14 12:19 pm Sale | 2022-12-31 | 13G | TRICIDA INC TCDAQ | Frazier Life Sciences Public Fund, L.P. | 1,500,000 2.500% | -2,082,093 (-58.13%) | Filing History |
| 2023-02-14 12:12 pm Purchase | 2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Frazier Life Sciences Public Fund, L.P. | 3,708,838 5.400% | 936,776 (+33.79%) | Filing History |
| 2023-02-14 12:09 pm Purchase | 2022-12-31 | 13G | Autolus Therapeutics plc AUTL | Frazier Life Sciences Public Fund, L.P. | 3,746,857 2.200% | 16,200 (+0.43%) | Filing History |
| 2023-02-14 12:08 pm Purchase | 2022-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Frazier Life Sciences Public Fund, L.P. | 5,223,655 6.300% | 495,104 (+10.47%) | Filing History |
| 2023-02-14 12:05 pm Purchase | 2022-12-31 | 13G | Chinook Therapeutics, Inc. KDNY | Frazier Life Sciences Public Fund, L.P. | 4,052,510 6.300% | 1,282,484 (+46.30%) | Filing History |
| 2023-02-14 12:03 pm Sale | 2022-12-31 | 13G | Gracell Biotechnologies Inc. GRCL | Frazier Life Sciences Public Fund, L.P. | 0 0.000% | -17,104,865 (Position Closed) | Filing History |
| 2023-02-14 11:58 am Purchase | 2022-12-31 | 13G | Allakos Inc. ALLK | Frazier Life Sciences Public Fund, L.P. | 4,792,000 5.600% | 1,892,000 (+65.24%) | Filing History |
| 2023-01-23 12:17 pm Purchase | 2023-01-13 | 13G | Theseus Pharmaceuticals, Inc. THRX | Frazier Life Sciences Public Fund, L.P. | 2,248,194 5.800% | 2,248,194 (New Position) | Filing History |
| 2022-12-30 2:15 pm Purchase | 2022-12-28 | 13D | KalVista Pharmaceuticals, Inc. KALV | Frazier Life Sciences Public Fund, L.P. | 3,238,859 9.500% | 1,666,667 (+106.01%) | Filing History |
| 2022-10-07 2:51 pm Purchase | 2022-10-05 | 13G | Trevi Therapeutics, Inc. TRVI | Frazier Life Sciences Public Fund, L.P. | 6,663,590 11.400% | 2,847,131 (+74.60%) | Filing History |